News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MerseyBIO Selects Autonomy Corporation PLC (AUTN) To Support Biotechnology Network


10/19/2005 5:12:52 PM

CAMBRIDGE, England, February 28 /PRNewswire-FirstCall/ -- Autonomy Corporation plc a global leader in infrastructure software for the enterprise, today announced that MerseyBIO, a biotechnology incubator organization, has implemented Autonomy's technology to power a network for the biotechnology community in Merseyside. The service, called esymbio, which has gone live this morning, aims to create an infrastructure that will foster collaboration between biotechnology companies, investors and public bodies to drive the development of the region's life sciences sector. The project is backed by public institutions such as the University of Liverpool and the North West Genetic Knowledge Park.

The development of life-changing and commercially successful pharmaceutical products relies on the close cooperation between academic and private research ventures, commercial organizations and public institutions. By building a joint portal for the biotechnology sector in Merseyside and beyond, esymbio brings these different groups together for the first time, encouraging an active exchange of ideas, knowledge and experience. Autonomy's advanced collaboration and expertise functionalities allow portal users to identify experts in their field automatically, establish contact and share information. Biotechnology companies can locate similar businesses in their sector, researchers are alerted to business opportunities and individuals have access to information on groups providing consultancy, manufacturing, packaging or design services for the industry.

As Autonomy has the unique expertise to aggregate content regardless of its format or source, the technology is further able to manage and locate all information stored in esymbio's databases through a single front end. Capitalizing on Autonomy's intelligence to understand the content of information rather than merely relying on metadata or keywords to locate relevant content, the right data can be found fast and effortlessly, opening a wealth of knowledge resources to the biotechnology community.

"The aim of esymbio is to provide a first meeting point for the industry, support the development of innovative products and create a prospering biotechnology sector", said Dr Geoff Wainwright, MerseyBIO Incubator Manager. Autonomy will help us to achieve our goals by supporting the exchange of information and providing a comprehensive knowledge network for the community."

Charlotte Herbert, Global Marketing Manager Autonomy, commented, "We are delighted to be involved in the esymbio project. Like many other organizations across all vertical sectors, esymbio will benefit from Autonomy's strength in connecting information and people at the right time, helping businesses to leverage the maximum value from their knowledge assets."

Autonomy's unique Intelligent Data Operating Layer (IDOL) integrates unstructured, semi-structured and structured information from multiple repositories through an understanding of their content. Autonomy grants organizations the flexibility to use advanced information retrieval or legacy-based approaches. At the heart of Autonomy's software is its ability to process text, voice and video and identify and rank the main concepts within them. It then automatically categorizes, links, summarizes, personalizes and delivers that information. Autonomy's technology also drives collaboration across different departments and interest groups and enables them to effectively leverage expertise. Autonomy's infrastructure technology is used to automate operations within enterprise information portals, customer relationship management, knowledge management, business intelligence and e-business applications, among others.

About Autonomy

Autonomy Corporation plc is a global leader in infrastructure software for the enterprise. Autonomy's technology powers applications dependent upon unstructured information including call centre, customer relationship management, knowledge management, enterprise portals, enterprise resource planning, online publishing and security applications. Autonomy's customer base includes more than 1,000 global companies including BAE Systems, Ford, Ericsson, Royal Sun Alliance, Sun Microsystems and public sector agencies including the U.S. Department of Defense, NASA and the U.S. Department of Energy. Strategic reseller and OEM partners include leading companies such as ATG, BEA, Business Objects, Citrix, Computer Associates, EDS, IBM Global Services, Novell, Novient, Veritas, Vignette, Supportsoft and Sybase. The company has offices worldwide.

The Autonomy Group of companies includes: Aungate, a leading supplier of electronic communications management technology for regulatory compliance in the enterprise; Audentify, a leading supplier of next-generation contact center technology; and Virage, a leading provider of rich media communication and content management software.

About MerseyBIO

MerseyBIO, a specialist business support unit based in the University of Liverpool, is leading the development of the life sciences sector on Merseyside through start-up and incubation, assisting local life sciences businesses and raising the profile of Liverpool as a leading UK life sciences location.

MerseyBIO is located in the state-of-the-art Business Incubator Building, a facility that provides laboratory and associated office space for up to 15 biotechnology companies as well as providing in-house specialist support to help young biotechnology companies through the difficult early days.

Caution Concerning Forward-Looking Statements

With the exception of historical information, the matters set forth in this news release are forward-looking statements that involve risks and uncertainties. A number of important factors could cause actual results to differ materially from those in the forward-looking statements. These factors include, among others, technology risks, including dependence on core technology; fluctuations in quarterly results; dependence on new product development; rapid technological and market change; reliance on sales by others; management of growth; dependence on key personnel; rapid expansion; growth of the Internet; financial risk management; and future growth subject to risks. These factors and other factors, which could cause actual results to differ materially are also discussed in the company's filings with the United States Securities and Exchange Commission, including Autonomy's Annual Report on Form 20-F and Registration Statements on Form F-1.

Autonomy Corporation plc

CONTACT: Wendy Johnson, MerseyBIO, +44-151-795-4126,WJohnson@merseybio.com. Charlotte Herbert, Autonomy Corporationplc, +44-1223-448-000, charlotteh@autonomy.com. MichelleParkinson, Outcast Communications, +1-415-392-8282,mparkinson@outcastpr.com. Edward Bridges, Financial Dynamics,+44-207-831-3113, edward.bridges@fd.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES